Literature DB >> 21669531

Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-).

S Kaleem Ahmed1, Jean-Louis G Etoga, Sarjubhai A Patel, Richard J Bridges, Charles M Thompson.   

Abstract

Evidence was acquired prior to suggest that the vesicular glutamate transporter (VGLUT) but not other glutamate transporters were inhibited by structures containing a weakly basic α-amino group. To test this hypothesis, a series of analogs using a hydantoin (pK(a)∼9.1) isostere were synthesized and analyzed as inhibitors of VGLUT and the obligate cystine-glutamate transporter (system x(c)(-)). Of the hydantoin analogs tested, a thiophene-5-carboxaldehyde analog 2l and a bis-hydantoin 4b were relatively strong inhibitors of VGLUT reducing uptake to less than 6% of control at 5mM but few inhibited system x(c)(-) greater than 50% of control. The benzene-2,4-disulfonic acid analog 2b and p-diaminobenzene analog 2e were also good hydantoin-based inhibitors of VGLUT reducing uptake by 11% and 23% of control, respectively, but neither analog was effective as a system x(c)(-) inhibitor. In sum, a hydantoin isostere adds the requisite chemical properties needed to produce selective inhibitors of VGLUT.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669531      PMCID: PMC3159025          DOI: 10.1016/j.bmcl.2011.05.018

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  Hydantoin derivatives. A new class of inhibitors of human leukocyte elastase.

Authors:  W C Groutas; M A Stanga; J C Castrisos; E J Schatz
Journal:  J Enzyme Inhib       Date:  1990

Review 2.  The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.

Authors:  D W Choi; S M Rothman
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

3.  Glutamate accumulation into synaptic vesicles.

Authors:  P E Kish; T Ueda
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

Review 4.  Glutamate as a neurotransmitter in the brain: review of physiology and pathology.

Authors:  B S Meldrum
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

5.  Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Authors:  Christina N Carrigan; Richard D Bartlett; C Sean Esslinger; Kimberly A Cybulski; Pakamas Tongcharoensirikul; Richard J Bridges; Charles M Thompson
Journal:  J Med Chem       Date:  2002-05-23       Impact factor: 7.446

6.  Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine.

Authors:  Sarjubhai A Patel; Brady A Warren; Joseph F Rhoderick; Richard J Bridges
Journal:  Neuropharmacology       Date:  2004-02       Impact factor: 5.250

Review 7.  Amino acid neurotransmitters and new approaches to anticonvulsant drug action.

Authors:  B Meldrum
Journal:  Epilepsia       Date:  1984       Impact factor: 5.864

8.  1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation.

Authors:  N A Meanwell; H R Roth; E C Smith; D L Wedding; J J Wright; J S Fleming; E Gillespie
Journal:  J Med Chem       Date:  1991-09       Impact factor: 7.446

Review 9.  Molecular diversity of glutamate receptors and implications for brain function.

Authors:  S Nakanishi
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

Review 10.  Experiments with kainate and quisqualate agonists and antagonists in relation to the sub-classification of 'non-NMDA' receptors.

Authors:  J C Watkins; P C Pook; D C Sunter; J Davies; T Honore
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

View more
  3 in total

1.  The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.

Authors:  Christina N Carrigan; Sarjubhai A Patel; Holly D Cox; Erin S Bolstad; John M Gerdes; Wesley E Smith; Richard J Bridges; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2013-12-25       Impact factor: 2.823

Review 2.  SLC17: a functionally diverse family of organic anion transporters.

Authors:  Richard J Reimer
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

3.  Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors.

Authors:  S A Neale; C S Copeland; V N Uebele; F J Thomson; T E Salt
Journal:  Neuropsychopharmacology       Date:  2013-01-07       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.